REGIONAL HEALTH PROPERTIES, INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that REGIONAL HEALTH PROPERTIES, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.16M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $18.34M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $17.16M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $35.93M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $26.69M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $17.58M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $20.13M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $22.05M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $25.15M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $27.60M | Apr 16, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | ($3.89M) | Apr 1, 2024 |
| FY2023 | Dec 31, 2022 | ($6.87M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($1.18M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($688.0K) | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $5.50M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($11.90M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($985.0K) | May 17, 2019 |
| FY2017 | Dec 31, 2016 | ($7.46M) | Apr 16, 2018 |
| FY2016 | Dec 31, 2015 | ($23.52M) | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | ($13.60M) | Mar 30, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $161.0K | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | ($821.0K) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($6.82M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $2.53M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $2.29M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $5.46M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($792.0K) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $5.14M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $4.52M | Apr 16, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.26M) | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.94M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $3.71M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($3.60M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $4.89M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.30M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $2.40M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $1.35M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $5.15M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | ($3.41M) | Apr 16, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $869.0K | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $530.0K | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $958.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $281.0K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $123.0K | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $450.0K | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $58.0K | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $338.0K | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $846.0K | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $1.50M | Apr 16, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $67.81M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $60.47M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $62.18M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $68.58M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $105.70M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $108.03M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $113.76M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $100.57M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $106.55M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $119.49M | Apr 16, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.77M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $63.38M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $62.00M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $64.86M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $95.30M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $96.92M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $102.02M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $94.42M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $88.68M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $95.99M | Apr 16, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $349.0K | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($2.92M) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $185.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $3.72M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $10.40M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $11.10M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | $11.74M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | $6.15M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | $17.87M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | ($37.95M) | Apr 16, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.59M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.59M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | $1.59M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $1.59M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | $1.59M | Feb 22, 2022 |
| FY2021 | Dec 31, 2019 | $1.59M | Feb 22, 2022 |
| FY2020 | Dec 31, 2018 | $2.11M | Mar 29, 2021 |
| FY2019 | Dec 31, 2017 | $2.11M | Mar 27, 2020 |
| FY2018 | Dec 31, 2016 | $2.11M | May 17, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($81.78M) | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | ($85.12M) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | ($81.90M) | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | ($121.41M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($114.54M) | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | ($113.36M) | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | ($112.67M) | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | ($118.17M) | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | ($106.28M) | May 17, 2019 |
| FY2017 | Dec 31, 2016 | ($99.59M) | Apr 16, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.00M | Apr 2, 2026 |
| FY2024 | Dec 31, 2024 | $582.0K | Mar 31, 2025 |
| FY2023 | Dec 31, 2023 | $1.00M | Apr 1, 2024 |
| FY2022 | Dec 31, 2022 | $800.0K | Apr 14, 2023 |
| FY2021 | Dec 31, 2021 | $6.80M | Feb 22, 2022 |
| FY2020 | Dec 31, 2020 | $4.20M | Mar 29, 2021 |
| FY2019 | Dec 31, 2019 | $4.40M | Mar 27, 2020 |
| FY2018 | Dec 31, 2018 | $2.40M | May 17, 2019 |
| FY2017 | Dec 31, 2017 | $1.82M | Apr 16, 2018 |
| FY2017 | Dec 31, 2016 | $14.05M | Apr 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $43.15M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | $49.72M | Apr 2, 2026 |
| FY2023 | Dec 31, 2023 | $50.74M | Apr 1, 2024 |
| FY2022 | Dec 31, 2022 | $52.18M | Apr 14, 2023 |
| FY2021 | Dec 31, 2021 | $52.88M | Feb 22, 2022 |
| FY2020 | Dec 31, 2020 | $54.44M | Mar 29, 2021 |
| FY2019 | Dec 31, 2019 | $55.36M | Mar 27, 2020 |
| FY2018 | Dec 31, 2018 | $81.31M | May 17, 2019 |
| FY2018 | Dec 31, 2017 | $73.10M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | $79.97M | Apr 16, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | 21 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (8) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | (5) | Apr 14, 2023 |
| FY2016 | Dec 31, 2016 | 0 | Apr 17, 2017 |
| FY2016 | Dec 31, 2015 | (1) | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | 21 | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | (8) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | (5) | Apr 14, 2023 |
| FY2016 | Dec 31, 2016 | 0 | Apr 17, 2017 |
| FY2016 | Dec 31, 2015 | (1) | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | 0 | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | 0 | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | 0 | Mar 31, 2014 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3.93M | Apr 2, 2026 |
| FY2025 | Dec 31, 2024 | 1.88M | Apr 2, 2026 |
| FY2024 | Dec 31, 2023 | 1.84M | Mar 31, 2025 |
| FY2023 | Dec 31, 2022 | 1.78M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 1.78M | Apr 14, 2023 |
| FY2021 | Dec 31, 2020 | 1.69M | Feb 22, 2022 |
| FY2020 | Dec 31, 2019 | 1.69M | Mar 29, 2021 |
| FY2019 | Dec 31, 2018 | 1.69M | Mar 27, 2020 |
| FY2018 | Dec 31, 2017 | 1.65M | May 17, 2019 |
| FY2017 | Dec 31, 2016 | 19.93M | Apr 16, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Dec 31, 2016 | $0 | Apr 17, 2017 |
| FY2016 | Dec 31, 2015 | $3.28M | Apr 17, 2017 |
| FY2015 | Dec 31, 2014 | $0 | Mar 30, 2016 |